The observed paradoxical effect of zoledronic acid on VEGF in wild type KRAS expessing NSCLC tumor and its consequences on improved vascularization/vessel stabilization may easily follow similar biological trends. This evidence concerns the gene KRAS and non-small cell lung carcinoma.